NBD AI Bulletin -- Ovctek China Inc (SZ 300595, close price: 38.17 yuan) on January 19 announced that the Company's net profit of 2022 expected to be about 571 million yuan ~682 million yuan, annual growth of 3%~23%.

Ovctek China Inc mainly engages in rigid gas permeable contact lenses and the medical industry, accounting for 96.33% and 13.67% of its revenue in 2021, respectively.

Ovctek China Inc's general manager and chairman is Tao Yuequn, male, 62 years old, PhD.

At of press time, the market value of the Company was 34.2 billion yuan.

(By Gao Han)

Disclaimer: The content and data of this article are for reference only and do not constitute investment advice. Please verify before use. Any action you take upon the information on this website is at your own risk.